Insider Trading activities of Heartware Ltd insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Heartware Ltd since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Heartware Ltd since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Heartware Ltd since 2005. The reporting company's ticker symbol is HTWR. The reporting company's CIK number is 1389072.
The total value of stock buying since 2005 is $13,890,596.
The total value of stock sales since 2005 is $286,112,498.
The total value of stock option exercises since 2005 is $8,575,776.


Go to page:  1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Heartware Ltd insiders (HTWR) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,388 82.09 196,030
2012-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 5,612 .00 0
2012-12-20 Farrell Lauren (VP, Finance) Sale 243 82.08 19,945
2012-12-20 Farrell Lauren (VP, Finance) Option Ex 750 .00 0
2012-12-14 Harrison Seth Loring (Director) Sale 75,922 81.06 6,153,857
2012-12-13 Hathaway David R (Chief Medical Officer) Sale 5,640 81.10 457,403
2012-12-13 Harrison Seth Loring (Director) Sale 108,571 81.69 8,869,164
2012-12-13 Wade Denis Newell (Director) Sale 2,163 81.00 175,203
2012-12-12 Hathaway David R (Chief Medical Officer) Sale 6,000 81.81 490,860
2012-12-12 Harrison Seth Loring (Director) Sale 11,480 81.82 939,293
2012-12-12 Wade Denis Newell (Director) Sale 337 82.50 27,802
2012-12-11 Hathaway David R (Chief Medical Officer) Sale 6,000 82.17 493,020
2012-12-11 Harrison Seth Loring (Director) Sale 55,358 82.18 4,549,320
2012-12-10 Harrison Seth Loring (Director) Sale 25,500 83.03 2,117,265
2012-12-07 Harrison Seth Loring (Director) Sale 48,130 80.92 3,894,438
2012-12-04 Thomas Robert Bain (Director) Sale 3,600 80.36 289,296
2012-12-03 Schuermann James (SVP, Sales & Marketing) Sale 2,500 81.64 204,100
2012-12-03 Thomas Robert Bain (Director) Sale 1,400 80.60 112,839
2012-12-03 Larose Jeffrey (Chief Scientific Officer) Sale 1,413 80.26 113,407
2012-11-21 Schuermann James (SVP, Sales & Marketing) Sale 800 84.37 67,494
2012-11-21 Larose Jeffrey (Chief Scientific Officer) Sale 909 84.37 76,690
2012-11-21 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,817 84.37 322,032
2012-11-21 Farrell Lauren (VP, Finance) Sale 536 84.74 45,420
2012-11-20 Schuermann James (SVP, Sales & Marketing) Option Ex 1,786 .00 0
2012-11-20 Larose Jeffrey (Chief Scientific Officer) Option Ex 2,322 .00 0
2012-11-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 8,572 .00 0
2012-11-20 Farrell Lauren (VP, Finance) Option Ex 536 .00 0
2012-11-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 84.01 84,010
2012-09-18 Hathaway David R (Chief Medical Officer) Sale 916 92.39 84,629
2012-09-18 Schuermann James (SVP, Sales & Marketing) Sale 915 92.39 84,536
2012-09-18 Larose Jeffrey (Chief Scientific Officer) Sale 1,200 92.39 110,868
2012-09-18 Godshall Douglas Evan (President & Chief Exec Officer) Sale 11,162 92.52 1,032,708
2012-09-18 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 7,500 40.48 303,600
2012-09-18 Farrell Lauren (VP, Finance) Sale 69 92.39 6,374
2012-09-17 Hathaway David R (Chief Medical Officer) Sale 3,338 92.09 307,396
2012-09-17 Schuermann James (SVP, Sales & Marketing) Sale 3,339 92.09 307,505
2012-09-17 Larose Jeffrey (Chief Scientific Officer) Sale 4,377 92.09 403,077
2012-09-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 13,352 92.09 1,229,652
2012-09-17 Farrell Lauren (VP, Finance) Sale 255 92.08 23,481
2012-09-16 Hathaway David R (Chief Medical Officer) Option Ex 10,000 .00 0
2012-09-16 Schuermann James (SVP, Sales & Marketing) Option Ex 10,000 .00 0
2012-09-16 Larose Jeffrey (Chief Scientific Officer) Option Ex 15,000 .00 0
2012-09-16 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 40,000 .00 0
2012-09-16 Farrell Lauren (VP, Finance) Option Ex 1,000 .00 0
2012-08-28 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,146 90.24 283,895
2012-08-28 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 3,146 40.01 125,871
2012-08-24 Godshall Douglas Evan (President & Chief Exec Officer) Sale 1,854 90.09 167,026
2012-08-24 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 1,854 40.38 74,864
2012-08-23 Thomas Robert Bain (Director) Sale 5,000 88.80 444,000
2012-08-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 88.98 222,450
2012-08-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,500 40.41 101,024
2012-08-01 Schuermann James (SVP, Sales & Marketing) Sale 1,000 89.04 89,040
2012-07-31 Larkin C Raymond Jr (Director) Option Ex 562 .00 0
2012-07-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 7,500 90.67 680,025
2012-07-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 7,500 39.38 295,350
2012-07-16 Harrison Seth Loring (Director) Sale 19,401 90.21 1,750,164
2012-07-13 Harrison Seth Loring (Director) Sale 9,199 90.00 827,910
2012-07-12 Harrison Seth Loring (Director) Sale 194 90.00 17,460
2012-07-03 Harrison Seth Loring (Director) Sale 525 90.00 47,250
2012-07-02 Schuermann James (VP, Sales & Marketing) Sale 1,000 90.00 90,000
2012-07-02 Harrison Seth Loring (Director) Sale 700 90.00 63,000
2012-07-02 Godshall Douglas Evan (President & Chief Exec Officer) Sale 5,000 90.00 450,000
2012-07-02 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 5,000 39.41 197,049
2012-06-25 Yocher Robert E (SVP, Regulatory & Quality) Sale 1,060 86.41 91,594
2012-06-23 Yocher Robert E (SVP, Regulatory & Quality) Option Ex 2,500 .00 0
2012-06-18 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 85.81 214,525
2012-06-18 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,500 38.81 97,025
2012-06-13 Thomas Robert Bain (Director) Sale 714 85.24 60,861
2012-06-12 Thomas Robert Bain (Director) Sale 5,000 85.61 428,050
2012-06-08 Schuermann James (VP, Sales & Marketing) Sale 1,000 85.00 85,000
2012-06-07 Stockman Robert Bernard (Director) Sale 3,025 82.61 249,895
2012-05-25 Thomas Robert Bain (Director) Sale 5,428 78.92 430,065
2012-05-23 Thomas Robert Bain (Director) Sale 957 78.34 74,971
2012-05-21 Larose Jeffrey (Chief Scientifc Officer) Sale 1,322 79.83 105,535
2012-05-18 Thomas Robert Bain (Director) Sale 6,429 78.67 505,737
2012-05-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 80.23 200,575
2012-05-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,500 38.20 95,500
2012-05-16 Thomas Robert Bain (Director) Sale 5,000 80.00 400,000
2012-05-15 Thomas Robert Bain (Director) Sale 5,000 80.73 403,650
2012-05-12 Harrison Seth Loring (Director) Option Ex 250 .00 0
2012-05-12 Bennett Christine Constance (Director) Option Ex 250 .00 0
2012-05-12 Wade Denis Newell (Director) Option Ex 250 .00 0
2012-05-12 Stockman Robert Bernard (Director) Option Ex 250 .00 0
2012-05-12 Thomas Robert Bain (Director) Option Ex 250 .00 0
2012-05-12 Barberich Timothy J (Director) Option Ex 250 .00 0
2012-05-12 Larkin C Raymond Jr (Director) Option Ex 250 .00 0
2012-05-11 Farrell Lauren (VP, Finance) Sale 475 81.73 38,821
2012-05-09 Schuermann James (VP, Sales & Marketing) Sale 313 77.18 24,157
2012-05-09 Larose Jeffrey (Chief Scientifc Officer) Sale 820 77.18 63,287
2012-05-09 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,445 77.18 265,885
2012-05-09 Farrell Lauren (VP, Finance) Sale 239 77.18 18,446
2012-05-08 Schuermann James (VP, Sales & Marketing) Option Ex 714 .00 0
2012-05-08 Larose Jeffrey (Chief Scientifc Officer) Option Ex 2,142 .00 0
2012-05-08 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 7,857 .00 0
2012-05-08 Farrell Lauren (VP, Finance) Option Ex 714 .00 0
2012-05-04 Harrison Seth Loring (Director) Option Ex 333 .00 0
2012-05-04 Bennett Christine Constance (Director) Option Ex 333 .00 0
2012-05-04 Wade Denis Newell (Director) Option Ex 333 .00 0
2012-05-04 Stockman Robert Bernard (Director) Option Ex 333 .00 0
2012-05-04 Thomas Robert Bain (Director) Option Ex 333 .00 0
2012-05-04 Barberich Timothy J (Director) Option Ex 333 .00 0
2012-05-04 Larkin C Raymond Jr (Director) Option Ex 333 .00 0
2012-05-01 Schuermann James (VP, Sales & Marketing) Sale 2,500 78.60 196,500
2012-04-26 Harrison Seth Loring (Director) Sale 30,019 78.04 2,342,682
2012-04-26 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 77.59 193,975
2012-04-26 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,500 39.94 99,850
2012-04-26 Farrell Lauren (VP, Finance) Sale 1,286 78.00 100,308
2012-04-26 Farrell Lauren (VP, Finance) Option Ex 1,286 25.31 32,544
2012-03-28 Knopf Lawrence J (General Counsel) Sale 2,258 67.46 152,324
2012-03-28 Knopf Lawrence J (General Counsel) Option Ex 5,250 .00 0
2012-03-06 Thomas Robert Bain (Director) Sale 5,999 71.37 428,130
2012-02-28 Wade Denis Newell (Director) Sale 6,000 74.50 447,000
2012-02-27 Wade Denis Newell (Director) Sale 12,000 73.75 885,000
2012-02-27 Thomas Robert Bain (Director) Sale 595 72.97 43,411
2012-02-24 Wade Denis Newell (Director) Sale 6,000 73.50 441,000
2012-02-24 Thomas Robert Bain (Director) Sale 1,376 74.00 101,824
2012-02-23 Thomas Robert Bain (Director) Sale 1,000 74.00 74,000
2012-02-22 Wade Denis Newell (Director) Sale 6,000 74.00 444,000
2012-02-21 Thomas Robert Bain (Director) Sale 571 73.88 42,182
2012-02-17 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,918 75.24 294,802
2012-02-17 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 1,620 41.19 66,727
2012-02-16 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,500 75.00 187,500
2012-02-16 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 2,500 41.29 103,225
2012-02-16 Farrell Lauren (VP, Finance) Sale 600 75.00 45,000
2012-02-01 Schuermann James (VP, Sales & Marketing) Sale 1,000 69.13 69,130
2012-01-31 Godshall Douglas Evan (President & Chief Exec Officer) Sale 5,000 70.07 350,349
2012-01-06 Godshall Douglas Evan (President & Chief Exec Officer) Sale 3,850 70.74 272,349
2012-01-06 Farrell Lauren (VP, Finance) Sale 499 72.00 35,928
2012-01-05 Schuermann James (VP, Sales & Marketing) Sale 808 70.00 56,560
2012-01-05 Godshall Douglas Evan (President & Chief Exec Officer) Sale 1,150 70.08 80,592
2012-01-03 Schuermann James (VP, Sales & Marketing) Sale 192 70.00 13,440
2012-01-03 Farrell Lauren (VP, Finance) Sale 672 70.00 47,040
2011-12-20 Hathaway David R (Chief Medical Officer) Sale 554 68.44 37,918
2011-12-20 Hathaway David R (Chief Medical Officer) Option Ex 1,263 .00 0
2011-12-20 Schuermann James (VP, Sales & Marketing) Sale 548 68.44 37,505
2011-12-20 Schuermann James (VP, Sales & Marketing) Option Ex 1,250 .00 0
2011-12-20 Mcintyre David (CFO & COO) Sale 3,125 68.44 213,890
2011-12-20 Mcintyre David (CFO & COO) Option Ex 3,125 .00 0
2011-12-20 Larose Jeffrey (Chief Scientifc Officer) Sale 1,072 68.44 73,373
2011-12-20 Larose Jeffrey (Chief Scientifc Officer) Option Ex 2,800 .00 0
2011-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Sale 2,461 68.44 168,443
2011-12-20 Godshall Douglas Evan (President & Chief Exec Officer) Option Ex 5,613 .00 0
2011-12-20 Farrell Lauren (VP, Finance) Sale 251 68.44 17,178
2011-12-20 Farrell Lauren (VP, Finance) Option Ex 750 .00 0
2011-12-19 Mcintyre David (CFO & COO) Sale 7,337 68.71 504,125
2011-12-19 Mcintyre David (CFO & COO) Option Ex 5,714 38.41 219,474
2011-12-13 Godshall Douglas Evan (President & Chief Exec Officer) Sale 800 70.00 56,000
2011-12-09 Godshall Douglas Evan (President & Chief Exec Officer) Sale 6,505 70.09 455,935
2011-12-07 Schuermann James (VP, Sales & Marketing) Sale 4,000 68.56 274,260
2011-12-01 Thomas Robert Bain (Director) Sale 2,500 68.13 170,325
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HTWR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Heartware Ltd (symbol HTWR, CIK number 1389072) see the Securities and Exchange Commission (SEC) website.